HEADER TRANSFERASE/INHIBITOR 05-JAN-22 7TEU TITLE CRYSTAL STRUCTURE OF JAK2 JH1 WITH TYPE II INHIBITOR YLIU-04-105-1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE JAK2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: JANUS KINASE 2,JAK-2; COMPND 5 EC: 2.7.10.2; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 OTHER_DETAILS: TYROSINE KINASE DOMAIN (JH1) SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: JAK2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET15B KEYWDS JAK2, TYROSINE KINASE, INHIBITOR, CYTOKINE SIGNALING, TRANSFERASE, KEYWDS 2 TRANSFERASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.R.HUBBARD REVDAT 3 25-OCT-23 7TEU 1 REMARK REVDAT 2 28-JUN-23 7TEU 1 JRNL REVDAT 1 21-JUN-23 7TEU 0 JRNL AUTH M.L.ARWOOD,Y.LIU,S.K.HARKINS,D.M.WEINSTOCK,L.YANG, JRNL AUTH 2 K.E.STEVENSON,O.D.PLANA,J.DONG,H.CIRKA,K.L.JONES, JRNL AUTH 3 A.T.VIRTANEN,D.G.GUPTA,A.CEAS,B.LAWNEY,A.YODA,C.LEAHY,M.HAO, JRNL AUTH 4 Z.HE,H.G.CHOI,Y.WANG,O.SILVENNOINEN,S.R.HUBBARD,T.ZHANG, JRNL AUTH 5 N.S.GRAY,L.S.LI JRNL TITL NEW SCAFFOLDS FOR TYPE II JAK2 INHIBITORS OVERCOME THE JRNL TITL 2 ACQUIRED G993A RESISTANCE MUTATION. JRNL REF CELL CHEM BIOL V. 30 618 2023 JRNL REFN ESSN 2451-9456 JRNL PMID 37290440 JRNL DOI 10.1016/J.CHEMBIOL.2023.05.007 REMARK 2 REMARK 2 RESOLUTION. 1.45 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19.2_4158 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.45 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.68 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 65621 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.194 REMARK 3 R VALUE (WORKING SET) : 0.194 REMARK 3 FREE R VALUE : 0.207 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.040 REMARK 3 FREE R VALUE TEST SET COUNT : 1998 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 28.6800 - 3.4900 0.94 4407 138 0.1819 0.1956 REMARK 3 2 3.4900 - 2.7700 1.00 4595 144 0.1879 0.1994 REMARK 3 3 2.7700 - 2.4200 1.00 4595 144 0.1930 0.2010 REMARK 3 4 2.4200 - 2.2000 1.00 4588 144 0.1881 0.2120 REMARK 3 5 2.2000 - 2.0400 1.00 4588 145 0.1837 0.1995 REMARK 3 6 2.0400 - 1.9200 1.00 4539 142 0.1898 0.1806 REMARK 3 7 1.9200 - 1.8300 1.00 4556 143 0.2082 0.2309 REMARK 3 8 1.8300 - 1.7500 1.00 4593 145 0.2091 0.2271 REMARK 3 9 1.7500 - 1.6800 1.00 4547 143 0.2033 0.2341 REMARK 3 10 1.6800 - 1.6200 1.00 4572 143 0.2043 0.2088 REMARK 3 11 1.6200 - 1.5700 1.00 4568 144 0.2137 0.2344 REMARK 3 12 1.5700 - 1.5300 1.00 4534 142 0.2162 0.2414 REMARK 3 13 1.5300 - 1.4900 1.00 4538 143 0.2207 0.2357 REMARK 3 14 1.4900 - 1.4500 0.96 4403 138 0.2402 0.2444 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.119 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 20.654 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 14.45 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.82 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 2358 REMARK 3 ANGLE : 1.037 3179 REMARK 3 CHIRALITY : 0.087 331 REMARK 3 PLANARITY : 0.008 406 REMARK 3 DIHEDRAL : 9.969 322 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7TEU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-JAN-22. REMARK 100 THE DEPOSITION ID IS D_1000261755. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-MAR-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 65627 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.450 REMARK 200 RESOLUTION RANGE LOW (A) : 28.700 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 4.800 REMARK 200 R MERGE (I) : 0.05000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 19.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.45 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.50 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.70 REMARK 200 R MERGE FOR SHELL (I) : 0.33000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 5.610 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3UGC REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.84 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.55 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 200 MM POTASSIUM PHOSPHATE MONOBASIC, REMARK 280 21% (W/V) PEG 3350, PH 4, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 53.73600 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.67900 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 53.73600 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 34.67900 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A1455 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 816 REMARK 465 GLY A 817 REMARK 465 SER A 818 REMARK 465 SER A 819 REMARK 465 HIS A 820 REMARK 465 HIS A 821 REMARK 465 HIS A 822 REMARK 465 HIS A 823 REMARK 465 HIS A 824 REMARK 465 HIS A 825 REMARK 465 SER A 826 REMARK 465 SER A 827 REMARK 465 GLY A 828 REMARK 465 LEU A 829 REMARK 465 VAL A 830 REMARK 465 PRO A 831 REMARK 465 ARG A 832 REMARK 465 GLY A 833 REMARK 465 SER A 834 REMARK 465 HIS A 835 REMARK 465 MET A 836 REMARK 465 GLU A 837 REMARK 465 ASP A 838 REMARK 465 ARG A 839 REMARK 465 ASP A 840 REMARK 465 PRO A 841 REMARK 465 THR A 842 REMARK 465 VAL A 1000 REMARK 465 LEU A 1001 REMARK 465 PRO A 1002 REMARK 465 GLN A 1003 REMARK 465 ASP A 1004 REMARK 465 LYS A 1005 REMARK 465 GLU A 1006 REMARK 465 PHE A 1007 REMARK 465 PHE A 1008 REMARK 465 LYS A 1009 REMARK 465 VAL A 1010 REMARK 465 LYS A 1011 REMARK 465 GLU A 1012 REMARK 465 GLY A 1132 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 857 CG CD CE NZ REMARK 470 GLN A 872 CG CD OE1 NE2 REMARK 470 GLU A 890 CD OE1 OE2 REMARK 470 GLN A 942 CD OE1 NE2 REMARK 470 THR A 998 OG1 CG2 REMARK 470 LYS A 999 CG CD CE NZ REMARK 470 GLU A1015 CG CD OE1 OE2 REMARK 470 LYS A1053 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 855 -134.27 -103.59 REMARK 500 THR A 875 -154.68 -119.17 REMARK 500 ARG A 975 -32.91 74.84 REMARK 500 ASP A 994 103.15 -163.30 REMARK 500 SER A1054 -8.55 83.18 REMARK 500 ASN A1085 13.89 82.35 REMARK 500 REMARK 500 REMARK: NULL DBREF 7TEU A 837 1132 UNP O60674 JAK2_HUMAN 837 1132 SEQADV 7TEU MET A 816 UNP O60674 INITIATING METHIONINE SEQADV 7TEU GLY A 817 UNP O60674 EXPRESSION TAG SEQADV 7TEU SER A 818 UNP O60674 EXPRESSION TAG SEQADV 7TEU SER A 819 UNP O60674 EXPRESSION TAG SEQADV 7TEU HIS A 820 UNP O60674 EXPRESSION TAG SEQADV 7TEU HIS A 821 UNP O60674 EXPRESSION TAG SEQADV 7TEU HIS A 822 UNP O60674 EXPRESSION TAG SEQADV 7TEU HIS A 823 UNP O60674 EXPRESSION TAG SEQADV 7TEU HIS A 824 UNP O60674 EXPRESSION TAG SEQADV 7TEU HIS A 825 UNP O60674 EXPRESSION TAG SEQADV 7TEU SER A 826 UNP O60674 EXPRESSION TAG SEQADV 7TEU SER A 827 UNP O60674 EXPRESSION TAG SEQADV 7TEU GLY A 828 UNP O60674 EXPRESSION TAG SEQADV 7TEU LEU A 829 UNP O60674 EXPRESSION TAG SEQADV 7TEU VAL A 830 UNP O60674 EXPRESSION TAG SEQADV 7TEU PRO A 831 UNP O60674 EXPRESSION TAG SEQADV 7TEU ARG A 832 UNP O60674 EXPRESSION TAG SEQADV 7TEU GLY A 833 UNP O60674 EXPRESSION TAG SEQADV 7TEU SER A 834 UNP O60674 EXPRESSION TAG SEQADV 7TEU HIS A 835 UNP O60674 EXPRESSION TAG SEQADV 7TEU MET A 836 UNP O60674 EXPRESSION TAG SEQADV 7TEU PHE A 1007 UNP O60674 TYR 1007 ENGINEERED MUTATION SEQADV 7TEU PHE A 1008 UNP O60674 TYR 1008 ENGINEERED MUTATION SEQRES 1 A 317 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 317 LEU VAL PRO ARG GLY SER HIS MET GLU ASP ARG ASP PRO SEQRES 3 A 317 THR GLN PHE GLU GLU ARG HIS LEU LYS PHE LEU GLN GLN SEQRES 4 A 317 LEU GLY LYS GLY ASN PHE GLY SER VAL GLU MET CYS ARG SEQRES 5 A 317 TYR ASP PRO LEU GLN ASP ASN THR GLY GLU VAL VAL ALA SEQRES 6 A 317 VAL LYS LYS LEU GLN HIS SER THR GLU GLU HIS LEU ARG SEQRES 7 A 317 ASP PHE GLU ARG GLU ILE GLU ILE LEU LYS SER LEU GLN SEQRES 8 A 317 HIS ASP ASN ILE VAL LYS TYR LYS GLY VAL CYS TYR SER SEQRES 9 A 317 ALA GLY ARG ARG ASN LEU LYS LEU ILE MET GLU TYR LEU SEQRES 10 A 317 PRO TYR GLY SER LEU ARG ASP TYR LEU GLN LYS HIS LYS SEQRES 11 A 317 GLU ARG ILE ASP HIS ILE LYS LEU LEU GLN TYR THR SER SEQRES 12 A 317 GLN ILE CYS LYS GLY MET GLU TYR LEU GLY THR LYS ARG SEQRES 13 A 317 TYR ILE HIS ARG ASP LEU ALA THR ARG ASN ILE LEU VAL SEQRES 14 A 317 GLU ASN GLU ASN ARG VAL LYS ILE GLY ASP PHE GLY LEU SEQRES 15 A 317 THR LYS VAL LEU PRO GLN ASP LYS GLU PHE PHE LYS VAL SEQRES 16 A 317 LYS GLU PRO GLY GLU SER PRO ILE PHE TRP TYR ALA PRO SEQRES 17 A 317 GLU SER LEU THR GLU SER LYS PHE SER VAL ALA SER ASP SEQRES 18 A 317 VAL TRP SER PHE GLY VAL VAL LEU TYR GLU LEU PHE THR SEQRES 19 A 317 TYR ILE GLU LYS SER LYS SER PRO PRO ALA GLU PHE MET SEQRES 20 A 317 ARG MET ILE GLY ASN ASP LYS GLN GLY GLN MET ILE VAL SEQRES 21 A 317 PHE HIS LEU ILE GLU LEU LEU LYS ASN ASN GLY ARG LEU SEQRES 22 A 317 PRO ARG PRO ASP GLY CYS PRO ASP GLU ILE TYR MET ILE SEQRES 23 A 317 MET THR GLU CYS TRP ASN ASN ASN VAL ASN GLN ARG PRO SEQRES 24 A 317 SER PHE ARG ASP LEU ALA LEU ARG VAL ASP GLN ILE ARG SEQRES 25 A 317 ASP ASN MET ALA GLY HET I6C A1201 44 HET GOL A1202 6 HETNAM I6C 3-{(4S)-2-[(CYCLOPROPANECARBONYL)AMINO]IMIDAZO[1,2- HETNAM 2 I6C B]PYRIDAZIN-6-YL}-N-{3-[(4-ETHYLPIPERAZIN-1-YL) HETNAM 3 I6C METHYL]-5-(TRIFLUOROMETHYL)PHENYL}-4-METHYLBENZAMIDE HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 I6C C32 H34 F3 N7 O2 FORMUL 3 GOL C3 H8 O3 FORMUL 4 HOH *200(H2 O) HELIX 1 AA1 GLU A 845 ARG A 847 5 3 HELIX 2 AA2 THR A 888 SER A 904 1 17 HELIX 3 AA3 SER A 936 HIS A 944 1 9 HELIX 4 AA4 LYS A 945 ILE A 948 5 4 HELIX 5 AA5 ASP A 949 LYS A 970 1 22 HELIX 6 AA6 ALA A 978 ARG A 980 5 3 HELIX 7 AA7 SER A 1016 TYR A 1021 5 6 HELIX 8 AA8 ALA A 1022 SER A 1029 1 8 HELIX 9 AA9 SER A 1032 THR A 1049 1 18 HELIX 10 AB1 SER A 1056 GLY A 1066 1 11 HELIX 11 AB2 GLY A 1071 ASN A 1084 1 14 HELIX 12 AB3 PRO A 1095 TRP A 1106 1 12 HELIX 13 AB4 ASN A 1109 ARG A 1113 5 5 HELIX 14 AB5 SER A 1115 ALA A 1131 1 17 SHEET 1 AA1 5 LEU A 849 LYS A 857 0 SHEET 2 AA1 5 GLY A 861 TYR A 868 -1 O VAL A 863 N GLY A 856 SHEET 3 AA1 5 GLU A 877 LEU A 884 -1 O VAL A 881 N GLU A 864 SHEET 4 AA1 5 ASN A 924 GLU A 930 -1 O LEU A 927 N LYS A 882 SHEET 5 AA1 5 TYR A 913 SER A 919 -1 N GLY A 915 O ILE A 928 SHEET 1 AA2 2 ILE A 982 ASN A 986 0 SHEET 2 AA2 2 ARG A 989 ILE A 992 -1 O LYS A 991 N LEU A 983 CRYST1 107.472 69.358 51.509 90.00 99.26 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009305 0.000000 0.001517 0.00000 SCALE2 0.000000 0.014418 0.000000 0.00000 SCALE3 0.000000 0.000000 0.019670 0.00000